Harrow Long Term Deferred Assets (Quarterly) Insights

Harrow, Inc. (HROW)

52.00 +1.18 (+2.32%) USD | NASDAQ | Feb 20, 16:00

52.03 +0.03 (+0.06%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for HROW.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	Upgrade
Assertio Holdings, Inc.	--
CapsoVision, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade